Brought to you by 
Stada plans to buy Russian Rx co Nizhpharm
03 Jan 2005
Executive Summary
Stada Arzneimittel AG (generics and branded and specialty drugs based on off-patent active ingredients) has signed a provisional agreement to acquire Nizhpharm JSC, one of Russia's top three or four pharmaceutical companies, for €80-85mm ($101-108mm).
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Generic Drugs
- OTC, Consumer
Deal Status
- Preliminary
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Stada plans to buy Russian Rx co Nizhpharm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice